Patent details

Basic Information

Publication number:

EP2028270

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP080199987

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Modified recombinant vaccinia viruses, uses thereof

French Title of Invention:

Virus de vaccinia recombinés modifiés et utilisations associées

German Title of Invention:

Modifizierte, rekombinante Vacciniaviren und deren Verwendungen

SPC Number:

Dates

Filing date:

18/06/2004

Grant date:

15/02/2012

EP Publication Date:

15/02/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/02/2009

EP B1 Publication Date:

15/02/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/06/2012

Expiration date:

18/06/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/06/2004

 

 

Name:

Genelux Corporation

Address:

3030 Bunker Hill Street Suite 310, San Diego, California 92109, United States (US)

Inventor

1

Name:

Szalay Aladar

Address:

United States (US)

2

Name:

Zhang Qian

Address:

United States (US)

3

Name:

Timiryasova Tatyana

Address:

United States (US)

4

Name:

Yu Yong A.

Address:

United States (US)

Priority

1

Priority Number:

03013826

Priority Date:

18/06/2003

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

03018478

Priority Date:

14/08/2003

Priority Country:

European Patent Office (EPO) (EP)

3

Priority Number:

03024283

Priority Date:

22/10/2003

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C12N 7/04;

Filing date	Document type	Number of pages